Bausch + Lomb Corporation (BLCO)

USD 18.24

(-3.24%)

Gross Profit Summary of Bausch + Lomb Corporation

  • Bausch + Lomb Corporation's latest annual gross profit in 2023 was 2.5 Billion USD , up 11.34% from previous year.
  • Bausch + Lomb Corporation's latest quarterly gross profit in 2024 Q3 was 660 Million USD , up 0.15% from previous quarter.
  • Bausch + Lomb Corporation reported a annual gross profit of 2.24 Billion USD in annual gross profit 2022, down -2.13% from previous year.
  • Bausch + Lomb Corporation reported a annual gross profit of 2.29 Billion USD in annual gross profit 2021, up 8.04% from previous year.
  • Bausch + Lomb Corporation reported a quarterly gross profit of 601 Million USD for 2024 Q1, down -15.59% from previous quarter.
  • Bausch + Lomb Corporation reported a quarterly gross profit of 659 Million USD for 2024 Q2, up 9.65% from previous quarter.

Annual Gross Profit Chart of Bausch + Lomb Corporation (2023 - 2018)

Historical Annual Gross Profit of Bausch + Lomb Corporation (2023 - 2018)

Year Gross Profit Gross Profit Growth
2023 2.5 Billion USD 11.34%
2022 2.24 Billion USD -2.13%
2021 2.29 Billion USD 8.04%
2020 2.12 Billion USD -13.22%
2019 2.45 Billion USD 4.21%
2018 2.35 Billion USD 0.0%

Peer Gross Profit Comparison of Bausch + Lomb Corporation

Name Gross Profit Gross Profit Difference
Alcon Inc. 5.6 Billion USD 55.349%
AptarGroup, Inc. 1.26 Billion USD -98.196%
Baxter International Inc. 4.97 Billion USD 49.668%
Becton, Dickinson and Company 9.15 Billion USD 72.643%
Haemonetics Corporation 676.53 Million USD -270.12%
Envista Holdings Corp 1.45 Billion USD -72.63%
ResMed Inc. 2.6 Billion USD 4.017%
Teleflex Incorporated 1.64 Billion USD -52.04%
Warby Parker Inc. 365.22 Million USD -585.607%
West Pharmaceutical Services, Inc. 1.12 Billion USD -121.75%